|
1
|
Yang JC and Rosenberg SA: Adoptive T-cell
therapy for cancer. Adv Immunol. 130:279–294. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jäkel CE, Hauser S, Rogenhofer S, Müller
SC, Brossart P and Schmidt-Wolf IG: Clinical studies applying
cytokine-induced killer cells for the treatment of renal cell
carcinoma. Clin Dev Immunol. 2012:4732452012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li R, Wang C, Liu L, Du C, Cao S, Yu J,
Wang SE, Hao X, Ren X and Li H: Autologous cytokine-induced killer
cell immunotherapy in lung cancer: A phase II clinical study.
Cancer Immunol Immunother. 61:2125–2133. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pan K, Guan XX, Li YQ, Zhao JJ, Li JJ, Qiu
HJ, Weng DS, Wang QJ, Liu Q, Huang LX, et al: Clinical activity of
adjuvant cytokine-induced killer cell immunotherapy in patients
with post-mastectomy triple-negative cancer patients. Clin Cancer
Res. 20:3003–3011. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gammaitoni L, Giraudo L, Leuci V,
Todorovic M, Mesiano G, Picciotto F, Pisacane A, Zaccagna A, Volpe
MG, Gallo S, et al: Effective activity of cytokine-induced killer
cells against autologous metastatic melanoma including cells with
stemness features. Clin Cancer Res. 19:4347–4358. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pan QZ, Wang QJ, Dan JQ, Pan K, Li YQ,
Zhang YJ, Zhao JJ, Weng DS, Tang Y, Huang LX, et al: A nomogram for
predicting the benefit of adjuvant cytokine-induced killer cell
immunotherapy in patients with hepatocellular carcinoma. Sci Rep.
5:92022015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rettinger E, Kuçi S, Naumann I, Becker P,
Kreyenberg H, Anzaghe M, Willasch A, Koehl U, Bug G, Ruthardt M, et
al: The cytotoxic potential of interleukin-15-stimulated
cytokine-induced killer cells against leukemia cells. Cytotherapy.
14:91–103. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Meng JX, Zhao MF, Chai X, Xiao X, Mu J, Li
Q, Deng Q and Li YM: IL-21 enhances anti-leukemia effect by acting
on both CD3+CD56+ CIK cells and regulatory T cells derived from
umbilical cord blood in vitro. Blood. 122:10512013.
|
|
9
|
Rutella S, Iudicone P, Bonanno G,
Fioravanti D, Procoli A, Lavorino C, Foddai ML, Lorusso D,
Martinelli E, Vacca M, et al: Adoptive immunotherapy with
cytokine-induced killer cells generated with a new good
manufacturing practice-grade protocol. Cytotherapy. 14:841–850.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tan G, Zhang X, Feng H, Luo H and Wang Z:
The therapeutic effect of cytokine-induced killer cells on
pancreatic cancer enhanced by dendritic cells pulsed with K-Ras
mutant peptide. Clin Dev Immunol. 2011:6493592011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ji Y, Hocker JD and Gattinoni L: Enhancing
adoptive T cell immunotherapy with microRNA therapeutics. Semin
Immunol. 28:45–53. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pan K, Li YQ, Wang W, Xu L, Zhang YJ,
Zheng HX, Zhao JJ, Qiu HJ, Weng DS, Li JJ, et al: The efficacy of
cytokine-induced killer cell infusion as an adjuvant therapy for
postoperative hepatocellular carcinoma patients. Ann Surg Oncol.
20:4305–4311. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Laport GG, Sheehan K, Baker J, Armstrong
R, Wong RM, Lowsky R, Johnston LJ, Shizuru JA, Miklos D, Arai S, et
al: Adoptive immunotherapy with cytokine-induced killer cells for
patients with relapsed hematologic malignancies after allogeneic
hematopoietic cell transplantation. Biol Blood Marrow Transplant.
17:1679–1687. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gao D, Li C, Xie X, Zhao P, Wei X, Sun W,
Liu HC, Alexandrou AT, Jones J, Zhao R and Li JJ: Autologous tumor
lysate-pulsed dendritic cell immunotherapy with cytokine-induced
killer cells improves survival in gastric and colorectal cancer
patients. PLoS One. 9:e938862014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bradford MM: A rapid and sensitive method
for the quantitation of microgram quantities of protein utilizing
the principle of protein-dye binding. Anal Biochem. 72:248–254.
1976. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Thorne SH, Negrin RS and Contag CH:
Synergistic antitumor effects of immune cell-viral biotherapy.
Science. 311:1780–1784. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen Y, Lin G, Guo ZQ, Zhou ZF, He ZY and
Ye YB: Effets of MICA expression on the prognosis of advanced
non-small cell lung cancer and the efficacy of CIK therapy. PLoS
One. 8:e690442013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Marin V, Pizzitola I, Agostoni V,
Attianese GM, Finney H, Lawson A, Pule M, Rousseau R, Biondi A and
Biagi E: Cytokine-induced killer cells for cell therapy of acute
myeloid leukemia: Improvement of their immune activity by
expression of CD33-specific chimeric receptors. Haematologica.
95:2144–2152. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zou Y, Li F, Hou W, Sampath P, Zhang Y and
Thorne SH: Manipulating the expression of chemokine receptors
enhances delivery and activity of cytokine-induced killer cells. Br
J Cancer. 110:1992–1999. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Batorov EV, Shevela EY, Tikhonova MA,
Batorova DS, Ushakova GY, Sizikova SA, Sergeevicheva VV, Gilevich
AV, Kryuchkova IV, Ostanin AA and Chernykh ER: Mesenchymal stromal
cells improve early lymphocyte recovery and T cell reconstitution
after autologous hematopoietic stem cell transplantation in
patients with malignant lymphomas. Cell Immunol. 297:80–86. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang J, Li C, Wang Y, Lv H, Guo Y, Dai H,
Wicha MS, Chang AE and Li Q: Cytokine-induced killer (CIK) cells
bound with anti-CD3/anti-CD133 bispecific antibodies target
CD133(high) cancer stem cells in vitro and in vivo. Clin Immunol.
149:156–168. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gargett T and Brown MP: Different cytokine
and stimulation conditions influence the expansion and immune
phenotype of third-generation chimeric antigen receptor T cells
specific for tumor antigen GD2. Cytotherapy. 17:487–495. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang J, Lou X, Shen H, Zellmer L, Sun Y,
Liu S, Xu N and Liao DJ: Isoforms of wild type proteins often
appear as low molecular weight bands on SDS-PAGE. Biotechnol J.
9:1044–1054. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chehayeb JF, Robertson AP, Martin RJ and
Geary TG: Proteomic analysis of adult ascaris suum fluid
compartments and secretory products. PLoS Negl Trop Dis.
8:e29392014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Othman N, Zainudin NS, Mohamed Z, Yahya
MM, Leow VM and Noordin R: Protein expression in sera of patients
with amoebic liver abscess (ALA): Potential use of haptoglobin as a
surrogate disease marker. Trop Biomed. 30:257–266. 2013.PubMed/NCBI
|
|
27
|
Jiang S, Lu Q, Hu S, Chen Y, Liu XL, Yang
Y and Ding MP: Proteomics comparison of the sera from multiple
sclerosis patients and neuromyelitis optica patients. Genet Mol
Res. 13:9292–9299. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Felix K, Hauck O, Fritz S, Hinz U,
Schnölzer M, Kempf T, Warnken U, Michel A, Pawlita M and Werner J:
Serum protein signatures differentiating autoimmune pancreatitis
versus pancreatic cancer. PLoS One. 8:e827552013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wen Q, Huang LT, Luo N, Wang YT, Li XY,
Mao HP, Zhang L, Dong XQ and Yu XQ: Proteomic profiling identifies
haptoglobin as a potential serum biomarker for steroid-resistant
nephrotic syndrome. Am J Nephrol. 36:105–113. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Langlois MR and Delanghe JR: Biological
and clinical significance of haptoglobin polymorphism in humans.
Clin Chem. 42:1589–1600. 1996.PubMed/NCBI
|
|
31
|
Flanagan JJ, Arjomandi A, Delanoy ML, Du
Paty E, Galea P, Laune D, Rieunier F, Walker RP and Binder SR:
Development of monoclonal antibodies to pre-haptoglobin 2 and their
use in an enzyme-linked immunosorbent assay (ELISA). J Immunol
Methods. 406:34–42. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bertaggia E, Scabia G, Dalise S, Lo Verso
F, Santini F, Vitti P, Chisari C, Sandri M and Maffei M:
Haptoglobin is required to prevent oxidative stress and muscle
atrophy. PLoS One. 9:e1007452014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Vanuytsel T, Vermeire S and Cleynen I: The
role of haptoglobin and its related protein, zonulin, in
inflammatory bowel disease. Tissue Barriers. 1:e273212013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Asleh R, Ward J, Levy NS, Safuri S,
Aronson D and Levy AP: Haptoglobin genotype-dependent differences
in macrophage lysosomal oxidative injury. J Biol Chem.
289:16313–16325. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Delanghe JR, Langlois MR and De Buyzere
ML: Haptoglobin polymorphism: A key factor in the proatherogenic
role of B cells? Atherosclerosis. 217:80–82. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Shen H, Song Y, Christopher CM, Wu T,
Bruce C, Scabia G, Galan A, Maffei M and Daniel RG: Haptoglobin
activates innate immunity to enhance acute transplant rejection in
mice. J Clin Invest. 122:383–387. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kreisel D and Goldstein DR: Innate
immunity and organ transplantation: Focus on lung transplantation.
Transpl Int. 26:2–10. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tan W, Wang F, Guo D, Ke Y, Shen Y, Lv C
and Zhang M: High serum level of haptoglobin is associated with the
response of 12 weeks methotrexate therapy in recent-onset
rheumatoid arthritis patients. Int J Rheum Dis. 19:482–489. 2016.
View Article : Google Scholar : PubMed/NCBI
|
